Brexpiprazole Reduces Survivin and Reverses EGFR Tyrosine Kinase Inhibitor Resistance in Lung and Pancreatic Cancer

Tomomi Sanomachi(Yamagata University), Masahiro Yamamoto(Kumamoto Health Science University)

Anticancer Research

September 1, 2019

10.21873/anticanres.13667

Cited by 20

Related Papers

Oncogenic Determination of a Broad Spectrum of Phenotypes of Hepatocyte-Derived Mouse Liver Tumors

|American Journal Of Pathology|2017|59

Olanzapine, an Atypical Antipsychotic, Inhibits Survivin Expression and Sensitizes Cancer Cells to Chemotherapeutic Agents

|Anticancer Research|2017|39

AS602801, an Anticancer Stem Cell Candidate Drug, Reduces Survivin Expression and Sensitizes A2780 Ovarian Cancer Stem Cells to Carboplatin and Paclitaxel

|Anticancer Research|2018|19